Literature DB >> 3100645

Comparison of different sandwich enzyme immunoassays for the quantitation of human apolipoproteins A-I and A-II.

D Y Dubois, F Cantraine, C L Malmendier.   

Abstract

Variants of a non-competitive enzyme immunoassay for human apolipoproteins A-I and A-II are described. The method developed is highly sensitive and highly specific. There is a good correlation between the reference technique (electroimmunoassay) and both apolipoprotein A-I and A-II assays (r=0.92). For the apolipoprotein A-I assay, seven simple treatments were studied. Two of these treatments (plasma plus Tween 20 and serum plus apo A-II) greatly increased the precision and the accuracy of the results. For the apo A-II measurement, no treatment of the samples is necessary, but plasma should be preferentially used rather than serum.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3100645     DOI: 10.1016/0022-1759(87)90374-7

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  4 in total

1.  Incubation of lipid emulsions with plasma lipoproteins modifies the fluidity of each particle.

Authors:  N F Chanson; J F Lontie; Y A Carpentier; C Motta
Journal:  Lipids       Date:  2001-08       Impact factor: 1.880

2.  LDL binding to lipid emulsion particles: effects of incubation duration, temperature, and addition of plasma subfractions.

Authors:  Nathalie F Chanson; Jean-François Lontie; Annette Gulik; Jacqueline Férézou; Yvon A Carpentier
Journal:  Lipids       Date:  2002-06       Impact factor: 1.880

3.  Effect of ALA-enriched food supply on cardiovascular risk factors in males.

Authors:  Isabelle Sioen; Mirjam Hacquebard; Gaëlle Hick; Veronique Maindiaux; Yvan Larondelle; Yvon A Carpentier; Stefaan De Henauw
Journal:  Lipids       Date:  2009-05-19       Impact factor: 1.880

4.  Changes in plasma LDL and HDL composition in patients undergoing cardiac surgery.

Authors:  M Hacquebard; A Ducart; D Schmartz; W J Malaisse; Y A Carpentier
Journal:  Lipids       Date:  2007-10-03       Impact factor: 1.880

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.